Colorectal cancer screening tests underused in US
This article was originally published in Clinica
Screening tests for colorectal cancer are still being underused in the US, according to a study published last week by the Centers for Disease Control (CDC). This is despite American Cancer Society guidelines published in 1997 which recommend regular screening of people aged 50 or over and the expansion last year of Medicare coverage for colorectal cancer testing.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.